Advanced search
Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 42, 2020 - Issue 6
Submit an article Journal homepage
223
Views
6
CrossRef citations to date
0
Altmetric
Original Research Paper

Low expression of FOSL1 is associated with favorable prognosis and sensitivity to radiation/pharmaceutical therapy in lower grade glioma

Jin ZhuBeijing Institute of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Ya-Peng ZhaoDepartment of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaView further author information
&
Yu-Qi ZhangDepartment of Neurosurgery, Yuquan Hospital, Tsinghua University, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 522-527 | Received 20 Dec 2019, Accepted 23 Mar 2020, Published online: 03 Apr 2020

References

  • Leu S, von Felten S, Frank S, et al. IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. J Neuro-Oncol. 2016;127(2):363–372.
  • Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.
  • Tang L, Deng L, Bai HX, et al. Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas. J Neuro-Oncol. 2018;139(3):563–571. .
  • de Botton S, Mondesir J, Willekens C, et al. IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med. 2016;7:171–180.
  • Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol. 2018;44(2):139–150.
  • Lee B, Uprety N, Jang YJ, et al. Fosl1 overexpression directly activates trophoblast-specific gene expression programs in embryonic stem cells. Stem Cell Res. 2018;26:95–102.
  • Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 2005;41(16):2449–2461.
  • Galvagni F, Orlandini M, Oliviero S. Role of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migration. Cell Adhes Migr. 2014;7(5):408–411.
  • Keshamouni VG. Excavation of FOSL1 in the Ruins of KRAS-driven lung cancer. Am J Resp Cell Mol. 2018;58(5):551–552.
  • Vallejo A, Valencia K, Vicent S. All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS. Mol Cell Oncol. 2017;4(3):e1314239.
  • Han Y, Zhao X, Sun Y, et al. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP‐1 signaling pathway. J Cell Physiol. 2019;234:3598–3612.
  • Zhu X, Liu H, Xu Z, et al. Expression and clinical significance of FOS-like antigen 1 in gastric adenocarcinoma. Pathol Res Pract. 2019;215(6):152394.
  • Kharman-Biz A, Gao H, Ghiasvand R, et al. Expression of activator protein-1 (AP-1) family members in breast cancer. Bmc Cancer. 2013;13(1):441.
  • Debinski W, Gibo DM. Fos-related antigen 1 modulates malignant features of glioma cells. Mol Cancer Res. 2005;3(4):237–249.
  • Kesari S, Bota DA. Fos-related antigen-1 (Fra-1) is a regulator of glioma cell malignant phenotype. Cancer Biol Ther. 2011;11(3):307–310.
  • Debinski W, Gibo DM. Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells. Cancer Biol Ther. 2011;11(2):254–262.
  • Kubota K, Kent LN, Rumi MA, et al. Dynamic regulation of AP-1 transcriptional complexes directs trophoblast differentiation. Mol Cell Biol. 2015;35(18):3163–3177.
  • Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4(5):E131–6.
  • Wagner EF. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis. 2002;61(Suppl 2):i40–2.
  • Chronis C, Fiziev P, Papp B, et al. Cooperative binding of transcription factors orchestrates reprogramming. Cell. 2017;168(3):442–459.
  • Li L, Zhang W, Zhao S, et al. FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma. Saudi J Gastroenterol. 2019;25(6):369–376.
  • Kent LN, Rumi MAK, Kubota K, et al. FOSL1 is integral to establishing the maternal-fetal interface. Mol Cell Biol. 2011;31(23):4801–4813.
  • Zhang K, Myllymäki S, Gao P, et al. Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT. Oncogene. 2017;36(41):5681–5694.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.